Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Biotech
Biotech
Eisai makes the case for lecanemab after 2nd patient death
Two deaths have dimmed the initial glow surrounding Eisai and Biogen’s next Alzheimer’s disease therapy lecanemab.
Annalee Armstrong
Nov 29, 2022 7:50pm
Full-Life acquires Focus-X in $245M biobucks deal
Nov 29, 2022 11:00am
Sponsored
Potential Modifier Gene Therapy for Degenerative Retinal Disease
Nov 28, 2022 8:00am
Almirall signs on with clinical trial project to collect data
Nov 29, 2022 10:32am
Sponsored
The future of Alzheimer’s disease research needs solutions
Nov 28, 2022 8:00am
Fierce Biotech Fundraising Tracker: Cajal, Rgenta and more
Nov 29, 2022 10:00am
